Uses, Dosage & Side Effects: Tagrisso Tablet
Tagrisso Tablet
| Generic name | osimertinib |
|---|---|
| Drug class | EGFR tyrosine kinase inhibitor (a type of targeted cancer therapy) |
| Forms | Tablet (40 mg), Tablet (80 mg) |
Tagrisso is a prescription tablet used to treat certain types of non-small cell lung cancer (NSCLC) in adults whose tumors have specific abnormal EGFR genes. It is a targeted therapy, not chemotherapy or immunotherapy.
Read the full guideUses, dosage, side effects, precautions, and sources, written from the same verified facts.
General information, not medical advice
Your prescriber and the leaflet in your pack know your situation. This page does not.
- Follow your prescriber and the leaflet
- Don't start, stop, or change a dose on your own
- Doses and warnings differ by country and product
Took too much, or feel seriously unwell? Get urgent medical help now.
Facts checked by a personFull disclaimer
